Related Experiment Videos
Endometrial papillary adenocarcinomas: two clinicopathological types
Summary
Endometrial papillary adenocarcinomas are distinct. Papillary serous adenocarcinoma has worse survival, while well-differentiated papillary adenocarcinoma shows a better prognosis, necessitating clear morphological and clinical differentiation.
Area of Science:
- Gynecologic Oncology
- Pathology
- Cancer Research
Background:
- Papillary adenocarcinomas constitute 10% of endometrial adenocarcinomas.
- Subclassification into papillary serous and well-differentiated types is crucial.
Purpose of the Study:
- To differentiate between papillary serous adenocarcinoma and well-differentiated papillary adenocarcinoma.
- To compare their clinical and prognostic features.
Main Methods:
- Histological review of 34 primary endometrial papillary adenocarcinoma cases.
- Comparison with a control group of 305 non-papillary endometrial adenocarcinomas.
- Analysis of age, race, myometrial invasion, staging, and survival.
Main Results:
- Papillary serous adenocarcinoma (25 patients) showed worse survival, deeper myometrial invasion, and peritoneal involvement.
- Well-differentiated papillary adenocarcinoma (9 patients) had similar outcomes to controls.
- Papillary serous adenocarcinoma patients were older and more likely to be Black.
Conclusions:
- Well-differentiated papillary adenocarcinoma is a distinct entity with a better prognosis.
- Morphological and clinical distinction from papillary serous adenocarcinoma is essential.
- This differentiation impacts patient management and outcomes.